Showing results (151-160 of 163) with videos related to
Sort By:
Pageof 17
Journal of Virology|June 5, 2015
New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin ALucie Fénéant, Julie Potel, Catherine François, et al.Journal of Biomedical Science|March 27, 2026
Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicitySaana Soppela, Henna-Maarit Kyröläinen, Alesia Levanova, et al.Diabetologia|November 6, 2013
Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreasSarah J Richardson, Pia Leete, Shalinee Dhayal, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2020
Donor-to-recipient transmission and reactivation in a kidney transplant recipient of an inherited chromosomally integrated HHV-6A: Evidence and outcomesVivien Petit, Pascale Bonnafous, Victor Fages, et al.Journal of Medical Virology|November 14, 2025
Infection of RAW 264.7 Cells by Murine Leukemia Virus-Derived Retroviral Pseudotype Expressing the Envelope Glycoprotein of EBOV Is Enhanced by AntibodiesChaldam Jespère Mbani, Famara Sane, Magloire Pandoua Nekoua, et al.Microbiology Spectrum|July 12, 2023
Vemurafenib Inhibits Acute and Chronic Enterovirus Infection by Affecting Cellular Kinase Phosphatidylinositol 4-Kinase Type IIIβMira Laajala, Marleen Zwaagstra, Mari Martikainen, et al.Diabetes|September 7, 2013
Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetesSami Oikarinen, Sisko Tauriainen, Didier Hober, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 18, 2022
Serum neutralization of SARS coronavirus 2 Omicron sublineages BA.1 and BA.2 and cellular immune responses 3 months after booster vaccinationEnagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, et al.The Lancet Regional Health. Europe|April 26, 2022
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older adults aged from 68 to 98 yearsEnagnon Kazali Alidjinou, Julie Demaret, Bénédicte Corroyer-Simovic, et al.Plos Pathogens|May 19, 2022
Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in miceSandrine Belouzard, Arnaud Machelart, Valentin Sencio, et al.Pageof 17